Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis

BACKGROUND: Vaccination against the oncogenic human papillomavirus (HPV) types 16 and 18 will reduce the prevalence of these types, thereby also reducing cervical cancer risk in unvaccinated women. This (measurable) herd effect will be limited at first, but is expected to increase over time. At a ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Naber, Steffie K., Matthijsse, Suzette M., Rozemeijer, Kirsten, Penning, Corine, de Kok, Inge M. C. M., van Ballegooijen, Marjolein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732771/
https://www.ncbi.nlm.nih.gov/pubmed/26824771
http://dx.doi.org/10.1371/journal.pone.0145548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732771/
https://www.ncbi.nlm.nih.gov/pubmed/26824771
http://dx.doi.org/10.1371/journal.pone.0145548

Ejemplares similares